Tranexamic acid in gynecologic surgery

References

• McPherson K, Metcalfe M, Herbert A, et al. Severe complications of hysterectomy: the VALUE study. BJOG. 2004;111(7):688–694.
   PubMed Web of Science ®Google Scholar
• Mäkinen J, Brummer T, Jalkanen J, et al. Ten years of progress—improved hysterectomy outcomes in Finland 1996–2006: a longitudinal observation study. BMJ Open. 2013;3(10):e003169.
   PubMed Web of Science ®Google Scholar
• LaMorte AI, Lalwani S, Diamond MP. Morbidity associated with abdominal myomectomy. Obstet Gynecol. 1993;82(6):897–900.
   PubMed Web of Science ®Google Scholar
• Crosignani PG, Vercellini P, Meschìa M, et al. GnRH agonists before surgery for uterine leiomyomas. A review. J Reprod Med. 1996;41(6):415–421.
   PubMed Web of Science ®Google Scholar
• Sanders AP, Chan WV, Tang J, et al. Surgical outcomes after uterine artery occlusion at the time of myomectomy: systematic review and meta-analysis. Fertil Steril. 2019;111(4):816–827.e4.
   PubMed Web of Science ®Google Scholar
• Zakhari A, Sanders AP, Murji A. Uterine artery occlusion at myomectomy. Fertil Steril. 2019;111(5):1030–1031.
   PubMed Web of Science ®Google Scholar
• Kalogiannidis I, Xiromeritis P, Prapas N, et al. Intravaginal misoprostol reduces intraoperative blood loss in minimally invasive myomectomy: a randomized clinical trial. Clin Exp Obstet Gynecol. 2011;38(1):46–49.
   PubMed Web of Science ®Google Scholar
• Hickman LC, Kotlyar A, Shue S, et al. Hemostatic techniques for myomectomy: an evidence-based approach. J Minim Invasive Gynecol. 2016;23(4):497–504.
   PubMed Web of Science ®Google Scholar
• Ng WCK, Jerath A, Wasowicz M. Tranexamic acid: a clinical review. Anaesthesiol Intensive Ther. 2015;47(4):339–350.
   PubMed Web of Science ®Google Scholar
• Watts G. Utako Okamoto. Lancet. 2016;387(10035):2286.
   PubMed Web of Science ®Google Scholar
• Okamoto S, Hijikata-Okunomiya A, Wanaka K, et al. Enzyme-controlling medicines: introduction. Semin Thromb Hemost. 1997;23(06):493–501.
   PubMed Web of Science ®Google Scholar
• Jimenez JJ, Iribarren JL, Lorente L, et al. Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: a case control study followed by a randomized double-blind controlled trial. Crit Care. 2007;11(6):R117.
   PubMed Web of Science ®Google Scholar
• Bramsen T. Serum and aqueous humour concentration of tranexamic acid after peroral administration. Acta Ophthalmol. 2009;57(3):455–460.
   Google Scholar
• Pilbrant Å, Schannong M, Vessman J. Pharmacokinetics and bioavailability of tranexamic acid. Eur J Clin Pharmacol. 1981;20(1):65–72.
   PubMed Web of Science ®Google Scholar
• Andersson L, Nilsson IM, Niléhn JE, et al. Experimental and clinical studies on AMCA, the antifibrinolytically active isomer of p‐aminomethyl cyclohexane carboxylic acid. Scand J Haematol. 2009;2(3):230–247.
   Google Scholar
• Bryant‐Smith AC, Lethaby A, Farquhar C, et al. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database Syst Rev. 2018;4:CD000249.
   PubMed Web of Science ®Google Scholar
• Singh S, Best C, Dunn S, et al. No. 292-abnormal uterine bleeding in pre-menopausal women. J Obstet Gynaecol Can. 2018;40(5):e391–e415.
   PubMed Web of Science ®Google Scholar
• ACOG committee opinion. Management of acute abnormal uterine bleeding in nonpregnant reproductive-aged women. Obstet Gynecol. 2013;121(557):891–896.
   PubMedGoogle Scholar
• Shakur H, Beaumont D, Pavord S, Gayet‐Ageron A, et al. Antifibrinolytic drugs for treating primary postpartum haemorrhage. Cochrane Database Syst Rev. 2018;2:CD012964.
   PubMed Web of Science ®Google Scholar
• Simonazzi G, Bisulli M, Saccone G, et al. Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta‐analysis of randomized controlled trials. Acta Obstet Gynecol Scand. 2016;95(1):28–37.
   PubMed Web of Science ®Google Scholar
• Sentilhes L, Winer N, Azria E, et al. Tranexamic acid for the prevention of blood loss after vaginal delivery. N Engl J Med. 2018;379(8):731–742.
   PubMed Web of Science ®Google Scholar
• Hajmurad OS, Choxi AA, Zahid Z, et al. Aortoiliac thrombosis following tranexamic acid administration during urgent cesarean hysterectomy: a case report. A&A Practice. 2017;9(3):90–93.
   Google Scholar
• Henry DA, Carless PA, Moxey AJ, et al. Anti‐fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2011;1:CD001886.
   Google Scholar
• Ker K, Edwards P, Perel P, et al. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ. 2012;344(1):e3054–e3054.
   PubMed Web of Science ®Google Scholar
• Perel P, Ker K, Uribe CHM, et al. Tranexamic acid for reducing mortality in emergency and urgent surgery. Cochrane Database Syst Rev. 2013;1:CD010245.
   PubMed Web of Science ®Google Scholar
• Roberts I, Shakur H, Coats T, et al. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. Health Technol Assess (Winchester, England). 2013;17(10):1.
   Web of Science ®Google Scholar
• Hammer A, Rositch AF, Kahlert J, et al. Global epidemiology of hysterectomy: possible impact on gynecological cancer rates. Am J Obstet Gynecol. 2015;213(1):23–29.
   PubMed Web of Science ®Google Scholar
• Topsoee MF, Bergholt T, Ravn P, et al. Anti-hemorrhagic effect of prophylactic tranexamic acid in benign hysterectomy—a double-blinded randomized placebo-controlled trial. Am J Obstet Gynecol. 2016;215(1):72. e1–72. e8.
   PubMed Web of Science ®Google Scholar
• Arthi PN, Jalakandan B, Gunaseelan S. Effect of prophylactic tranexamic acid on blood conservation in Indian women undergoing abdominal hysterectomy. Int J Reprod Contracept Obstet Gynecol. 2018;7(9):3538–3545.
   Google Scholar
• Fusca L, Perelman I, Fergusson D, et al. The effectiveness of tranexamic acid at reducing blood loss and transfusion requirement for women undergoing myomectomy: a systematic review and meta-analysis. J Obstet Gynaecol Can. 2018. 41(8):1185–1192.e1.
   PubMed Web of Science ®Google Scholar
• Shady NW, Sallam HF, Fahmy H. Reducing blood loss during open myomectomy with intravenous versus topical tranexamic acid: a double-blinded randomized placebo-controlled trial. Middle East Fertil Soc J. 2018;23(3):225–231.
   Web of Science ®Google Scholar
• Martin‐Hirsch PPL, Bryant A. Interventions for preventing blood loss during the treatment of cervical intraepithelial neoplasia. Cochrane Database Syst Rev. 2013;6:CD001421.
   Google Scholar
• Vu M, Yu J, Awolude OA, et al. Cervical cancer worldwide. Curr Prob Cancer. 2018;42(5):457–465.
   PubMed Web of Science ®Google Scholar
• Bansal N, Herzog TJ, Shaw RE, et al. Primary therapy for early-stage cervical cancer: radical hysterectomy vs radiation. Am J Obstet Gynecol. 2009;201(5):485.e1–9.
   PubMed Web of Science ®Google Scholar
• Celebi N, Celebioglu B, Selcuk M, et al. The role of antifibrinolytic agents in gynecologic cancer surgery. Saudi Med J. 2006;27(5):637–641.
   PubMed Web of Science ®Google Scholar
• Reid BM, Permuth JB, Sellers TA. Epidemiology of ovarian cancer: a review. Cancer Biol Med. 2017;14(1):9–32.
   PubMed Web of Science ®Google Scholar
• Elattar A, Bryant A, Winter-Roach BA, et al. Optimal primary surgical treatment for advanced epithelial ovarian cancer. Cochrane Database Syst Rev. 2011;10(8):CD007565.
   Google Scholar
• Amato A, Pescatori M. Perioperative blood transfusions and recurrence of colorectal cancer. Cochrane Database Syst Rev. 2006;1:CD005033.
   Google Scholar
• Rosenberg SA, Seipp CA, White DE, et al. Perioperative blood transfusions are associated with increased rates of recurrence and decreased survival in patients with high-grade soft-tissue sarcomas of the extremities. J Clin Oncol. 1985;3(5):698–709.
   PubMed Web of Science ®Google Scholar
• You D, Yoo YK, Choi HJ, et al. Blood transfusion as an independent risk factor for recurrence after hepatocellular carcinoma resection. Transplantation. 2018;102:S906.
   Web of Science ®Google Scholar
• Linder BJ, Frank I, Cheville JC, et al. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy. Eur Urol. 2013;63(5):839–845.
   PubMed Web of Science ®Google Scholar
• Kietpeerakool C, Supoken A, Laopaiboon M, et al. Effectiveness of tranexamic acid in reducing blood loss during cytoreductive surgery for advanced ovarian cancer. Cochrane Database Syst Rev. 2016;1:CD011732.
   Google Scholar
• Lundin ES, Johansson T, Zachrisson H, et al. Single‐dose tranexamic acid in advanced ovarian cancer surgery reduces blood loss and transfusions: double‐blind placebo‐controlled randomized multicenter study. Acta Obstet Gynecol Scand. 2014;93(4):335–344.
   PubMed Web of Science ®Google Scholar
• Wallace SK, Halverson JW, Jankowski CJ, et al. Optimizing blood transfusion practices through bundled intervention implementation in patients with gynecologic cancer undergoing laparotomy. Obstet Gynecol. 2018;131(5):891–898.
   PubMed Web of Science ®Google Scholar
• Hoover KW, Tao G, Kent CK. Trends in the diagnosis and treatment of ectopic pregnancy in the United States. Obstet Gynecol. 2010;115(3):495–502.
   PubMed Web of Science ®Google Scholar
• Van Den Eeden SK, Shan J, Bruce C, et al. Ectopic pregnancy rate and treatment utilization in a large managed care organization. Obstet Gynecol. 2005;105(5, Part 1):1052–1057.
   PubMed Web of Science ®Google Scholar
• Hendrix NW, Chauhan SP, Mobley J, et al. Risk factors associated with blood transfusion in ectopic pregnancy. J Reprod Med. 1999;44(5):433–440.
   PubMed Web of Science ®Google Scholar
• Takeda A, Manabe S, Mitsui T, et al. Management of patients with ectopic pregnancy with massive hemoperitoneum by laparoscopic surgery with intraoperative autologous blood transfusion. J Minim Invasive Gynecol. 2006;13(1):43–48.
   PubMed Web of Science ®Google Scholar
• Yamada T, Okamoto Y, Kasamatsu H, et al. Intraoperative autologous blood transfusion for hemoperitoneum resulting from ectopic pregnancy or ovarian bleeding during laparoscopic surgery. JSLS: J Soc Laparoend Surgeons. 2003;7(2):97–100.
   Google Scholar
• Murphy NC, Hayes NE, Ainle FBN, et al. Jehovah’s Witness patients presenting with ruptured ectopic pregnancies: two case reports. J Med Case Rep. 2014;8(1):312.
   PubMedGoogle Scholar
• Arowojolu A, Ogunbode O. Cervical ectopic pregnancy managed with methotrexate and tranexamic acid: a case report. Afr J Med Med Sci. 2014;43(4):361–364.
   PubMedGoogle Scholar
• Zambrano N, Reilly J, Moretti M, et al. Double balloon cervical ripening catheter for control of massive hemorrhage in a cervical ectopic pregnancy. Case Rep Obstet Gynecol. 2017;2017:1–4.
   Google Scholar
• Bianchi P, Salvatori MM, Torcia F, et al. Cervical pregnancy. Fertil Steril. 2011;95(6):2123.e3–23.e4.
   PubMed Web of Science ®Google Scholar
• Ergun B, Bastu E, Ozsurmeli M, et al. Tranexamic acid: a potential adjunct to resectoscopic endometrial ablation. Int Surg. 2012;97(4):310–314.
   PubMed Web of Science ®Google Scholar
• Mousa SA, Yassen AM, Alhadary HS, et al. Hematological profile and transfusion requirement during hysteroscopic myomectomy: a comparative study between oxytocin and tranexamic acid infusion. Egypt J Anaesth. 2012;28(2):125–132.
   Google Scholar
• van den Brûle F, Buicu C, Dequesne J, et al. Treatment of peroperative hemorrage during operative hysteroscopy using bipolar energy with intrauterine tranexamic acid: a case report. Gynecol Surg. 2004;1(3):205–206.
   Google Scholar
• Sayyahmelli M. Moosazadeh R, Mostafa GP, Nazari F. Comparison of the intraoperative outcomes of intrauterine instillation of epsilon-aminocaproic acid and intravenous oxytocin in hysteroscopy surgeries. Int J Women Health Reprod Sci. 2016;4(2):68–72.
   Web of Science ®Google Scholar
• Manizheh S-M, Elaheh O, Simin T, et al. The effect of intrauterine instillation of E-Aminocaproic Acid during hysteroscopic operations in the management of intractable uterine hemorrhage: a randomized clinical trial. Life Sci J. 2013;10:1369–1374.
   Google Scholar
• Ferring-Pharmaceuticals-Inc. Lysteda (tranexamic acid) tablets: highlights of Prescribing Information 2013. 2013; [cited 2019 Jun 22]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022430s004lbl.pdf
   Google Scholar
• Pfizer-Injectables. Cyklokapron (tranexamic acid injection). 2017; [cited 2019 Jun 22]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019281s041lbl.pdf
   Google Scholar
• Pfizer-Canada-Inc. Product Monograph GD-Tranexamic Acid. 2018; [cited 2019 Jun 22]. Available from: https://www.pfizer.ca/sites/g/files/g10050796/f/201810/GD-Tranexamic_Acid_PM_E_220955_22Oct2018.pdf
   Google Scholar
• Prasad R, Patki A, Padhy S, et al. Single intravenous bolus versus perioperative continuous infusion of tranexamic acid to reduce blood loss in abdominal oncosurgical procedures: a prospective randomized double-blind clinical study. J Anaesthesiol Clin Pharmacol. 2018;34(4):529–534.
   PubMed Web of Science ®Google Scholar
• Hourlier H, Reina N, Fennema P. Single dose intravenous tranexamic acid as effective as continuous infusion in primary total knee arthroplasty: a randomised clinical trial. Arch Orthop Trauma Surg. 2015;135(4):465–471.
   PubMed Web of Science ®Google Scholar
• Breau RH, Kokolo MB, Punjani N, et al. The effects of lysine analogs during pelvic surgery: a systematic review and meta-analysis. Transfus Med Rev. 2014;28(3):145–155.
   PubMed Web of Science ®Google Scholar
• Topsoee MF, Settnes A, Ottesen B, et al. A systematic review and meta‐analysis of the effect of prophylactic tranexamic acid treatment in major benign uterine surgery. Int J Gynecol Obstet. 2017;136(2):120–127.
   PubMed Web of Science ®Google Scholar
• Kagoma YK, Crowther MA, Douketis J, et al. Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. Thromb Res. 2009;123(5):687–696.
   PubMed Web of Science ®Google Scholar
• Ma SA, Brindle W, Burton G, et al. Tranexamic acid is associated with less blood transfusion in off-pump coronary artery bypass graft surgery: a systematic review and meta-analysis. J Cardiothorac Vasc Anesth. 2011;25(1):26–35.
   PubMed Web of Science ®Google Scholar
• Murkin JM, Falter F, Granton J, et al. High-dose tranexamic acid is associated with nonischemic clinical seizures in cardiac surgical patients. Anesth Analg. 2010;110(2):350–353.
   PubMed Web of Science ®Google Scholar
• Lin Z, Xiaoyi Z. Tranexamic acid-associated seizures: a meta-analysis. Seizure. 2016;36:70–73.
   PubMed Web of Science ®Google Scholar
• Cravens GT, Brown MJ, Brown DR, et al. Antifibrinolytic therapy use to mitigate blood loss during staged complex major spine surgery: postoperative visual color changes after tranexamic acid administration. Anesthesiology. 2006;105(6):1274–1276.
   PubMed Web of Science ®Google Scholar
• Kitamura H, Matsui I, Itoh N, et al. Tranexamic acid-induced visual impairment in a hemodialysis patient. J Clin Exp Nephrol. 2003;7(4):311–314.
   Google Scholar
• Shaaban MM, Ahmed MR, Farhan RE, et al. Efficacy of tranexamic acid on myomectomy-associated blood loss in patients with multiple myomas: a randomized controlled clinical trial. Reprod Sci. 2016;23(7):908–912.
   PubMed Web of Science ®Google Scholar